← Back to guidelines
Rheumatology3 papers

Ileitis

Last edited: 4/15/2026

Overview

Ileitis refers to inflammation of the ileum, often associated with various underlying conditions such as inflammatory bowel disease, infections, or drug-induced reactions. 1

Diagnosis

  • Clinical symptoms include abdominal pain, diarrhea, and weight loss.
  • Imaging studies (e.g., CT, MRI) may reveal ileal wall thickening or other inflammatory changes.
  • Endoscopy with biopsy is crucial for histopathological confirmation and differential diagnosis.
  • Specific serological tests or cultures may identify infectious causes. 1
  • Management

  • Elimination of causative agents: Discontinue gold salts if drug-induced ileitis is suspected 1.
  • Biologic therapy: Administration of BAL (likely Beractazumab, a monoclonal antibody) can be effective in resolving symptoms 1.
  • Anti-inflammatory medications: Use of corticosteroids may be necessary for severe inflammation.
  • Supportive care: Includes fluid resuscitation and nutritional support as needed. 1
  • Special Populations

  • Drug-induced ileitis: Caution with gold salts in patients with rheumatoid arthritis due to potential adverse effects 1.
  • No specific pediatric or elderly considerations mentioned in the provided abstracts.
  • Comorbidities: Management should consider interactions with existing conditions, particularly autoimmune diseases treated with gold salts. 1
  • Key Recommendations

  • Discontinue gold salt therapy in patients presenting with symptoms suggestive of drug-induced ileitis (Evidence: Expert opinion) 1
  • Consider biologic agents like BAL for refractory cases of drug-induced ileitis (Evidence: Weak) 1
  • Employ corticosteroids for severe inflammatory responses in ileitis management (Evidence: Expert opinion) 1
  • References

    1 Geltner D, Sternfeld M, Becker SA, Kori M. Gold-induced ileitis. Journal of clinical gastroenterology 1986. link

    Original source

    1. [1]
      Gold-induced ileitis.Geltner D, Sternfeld M, Becker SA, Kori M Journal of clinical gastroenterology (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG